These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 15497700)
1. Early prediction of pharmaceutical oxidation pathways by computational chemistry and forced degradation. Reid DL; Calvitt CJ; Zell MT; Miller KG; Kingsmill CA Pharm Res; 2004 Sep; 21(9):1708-17. PubMed ID: 15497700 [TBL] [Abstract][Full Text] [Related]
2. Forced Oxidative Degradation Pathways of the Imidazole Moiety of Daclatasvir. Huang Y; Su BN; Marshall J; Miller SA J Pharm Sci; 2019 Oct; 108(10):3312-3318. PubMed ID: 31145924 [TBL] [Abstract][Full Text] [Related]
3. The application of electrochemistry to pharmaceutical stability testing--comparison with in silico prediction and chemical forced degradation approaches. Torres S; Brown R; Szucs R; Hawkins JM; Zelesky T; Scrivens G; Pettman A; Taylor MR J Pharm Biomed Anal; 2015 Nov; 115():487-501. PubMed ID: 26299525 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive Insight into Chemical Stability of Important Antidiabetic Drug Vildagliptin Using Chromatography (LC-UV and UHPLC-DAD-MS) and Spectroscopy (Mid-IR and NIR with PCA). Gumieniczek A; Berecka-Rycerz A; Fornal E; Żyżyńska-Granica B; Granica S Molecules; 2021 Sep; 26(18):. PubMed ID: 34577104 [TBL] [Abstract][Full Text] [Related]
5. Use of the hyphenated LC-MS/MS technique and NMR/IR spectroscopy for the identification of exemestane stress degradation products during the drug development. Stolarczyk EU; Rosa A; Kubiszewski M; Zagrodzka J; Cybulski M; Kaczmarek Ł Eur J Pharm Sci; 2017 Nov; 109():389-401. PubMed ID: 28865686 [TBL] [Abstract][Full Text] [Related]
6. Structural identification and characterization of potential degradants of zotarolimus on zotarolimus-coated drug-eluting stents. Chen Q; Zielinski D; Chen J; Nowak S; Zhou CC J Pharm Biomed Anal; 2009 Dec; 50(5):778-86. PubMed ID: 19581067 [TBL] [Abstract][Full Text] [Related]
7. Use of LC-MS/TOF, LC-MS(n), NMR and LC-NMR in characterization of stress degradation products: Application to cilazapril. Narayanam M; Sahu A; Singh S J Pharm Biomed Anal; 2015; 111():190-203. PubMed ID: 25890215 [TBL] [Abstract][Full Text] [Related]
9. Stability-indicating HPLC method development and structural elucidation of novel degradation products in posaconazole injection by LC-TOF/MS, LC-MS/MS and NMR. Yang Y; Zhu X; Zhang F; Li W; Wu Y; Ding L J Pharm Biomed Anal; 2016 Jun; 125():165-77. PubMed ID: 27023129 [TBL] [Abstract][Full Text] [Related]
10. A prediction system of oxidation reaction as a solid-state stress condition: applied to a pyrrole-containing pharmaceutical compound. Kawaguchi-Murakami Y; Fukutsu N; Kajiro T; Araki T; Murakami T; Kawasaki T; Kishi N; Konno M J Pharm Biomed Anal; 2009 Oct; 50(3):328-35. PubMed ID: 19497698 [TBL] [Abstract][Full Text] [Related]
11. Forced degradation studies of elagolix sodium with the implementation of high resolution LC-UV-PDA-MS Zhong X; Lv Q; Yong Q; Hu W; Li D; Ji S; Zhan L; Chen W; Li M; Lin J; Sun C J Pharm Biomed Anal; 2023 Feb; 224():115198. PubMed ID: 36495708 [TBL] [Abstract][Full Text] [Related]
12. Forced degradation of fentanyl: identification and analysis of impurities and degradants. Garg A; Solas DW; Takahashi LH; Cassella JV J Pharm Biomed Anal; 2010 Nov; 53(3):325-34. PubMed ID: 20462721 [TBL] [Abstract][Full Text] [Related]
13. Prediction of drug candidates' sensitivity toward autoxidation: computational estimation of C-H dissociation energies of carbon-centered radicals. Andersson T; Broo A; Evertsson E J Pharm Sci; 2014 Jul; 103(7):1949-1955. PubMed ID: 24823496 [TBL] [Abstract][Full Text] [Related]
14. Study of the forced degradation behavior of prasugrel hydrochloride by liquid chromatography with mass spectrometry and liquid chromatography with NMR detection and prediction of the toxicity of the characterized degradation products. Singh DK; Sahu A; Handa T; Narayanam M; Singh S J Sep Sci; 2015 Sep; 38(17):2995-3005. PubMed ID: 26114771 [TBL] [Abstract][Full Text] [Related]
15. ESI-MSn and LC-ESI-MS studies to characterize forced degradation products of bosentan and a validated stability-indicating LC-UV method. Bansal G; Singh R; Saini B; Bansal Y J Pharm Biomed Anal; 2013 Jan; 72():186-97. PubMed ID: 22999302 [TBL] [Abstract][Full Text] [Related]
16. LC-MS-MS Characterization of Forced Degradation Products of Fidarestat, a Novel Aldose Reductase Inhibitor: Development and Validation of a Stability-Indicating RP-HPLC Method. Talluri MV; Khatoon L; Kalariya PD; Chavan BB; Ragampeta S J Chromatogr Sci; 2015 Oct; 53(9):1588-96. PubMed ID: 26014964 [TBL] [Abstract][Full Text] [Related]
17. pH control of nucleophilic/electrophilic oxidation. Freed AL; Strohmeyer HE; Mahjour M; Sadineni V; Reid DL; Kingsmill CA Int J Pharm; 2008 Jun; 357(1-2):180-8. PubMed ID: 18400425 [TBL] [Abstract][Full Text] [Related]
18. Impurity Profile of Bronchodilators used in Asthma: A Critical Review. Prajapati KJ; Kothari CS Curr Drug Discov Technol; 2018; 15(4):272-304. PubMed ID: 28875855 [TBL] [Abstract][Full Text] [Related]
19. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method. Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610 [TBL] [Abstract][Full Text] [Related]